| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 162,707 | 174,434 | 127,900 | 156,536 | | Cost of Revenue | 125,509 | 90,748 | 101,803 | 112,167 | | | Gross Profit | 37,198 | 83,686 | 26,097 | 44,369 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (11,211) | 24,177 | 4,835 | 11,686 | | Non Recurring |
-
|
-
|
-
| (4,269) | | Others | 27,290 | 27,482 | 27,559 | 27,816 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 21,119 | 32,027 | (6,297) | 9,136 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 14 | 15 | 14 | 30 | | Earnings Before Interest And Taxes | 21,133 | 32,042 | (6,283) | 9,166 | | Interest Expense | 9,172 | 9,887 | 9,860 | 12,003 | | Income Before Tax | 11,961 | 22,155 | (16,143) | (2,837) | | Income Tax Expense | 1,831 | 7,245 | (3,941) | (1,966) | | Minority Interest | 357 | (13) | (344) | (1,123) | | | | Net Income From Continuing Ops | 10,487 | 14,897 | (12,546) | (1,994) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 10,487 | 14,897 | (12,546) | (1,994) | | Preferred Stock And Other Adjustments | 13,011 | (6,689) | (6,322) | (5,624) | | | Net Income Applicable To Common Shares | $23,498 | $8,208 | ($18,868) | ($7,618) |
|
0.51% Nasdaq 
Income Statement
